Copyright
©The Author(s) 2022.
World J Gastroenterol. Jul 28, 2022; 28(28): 3666-3681
Published online Jul 28, 2022. doi: 10.3748/wjg.v28.i28.3666
Published online Jul 28, 2022. doi: 10.3748/wjg.v28.i28.3666
Figure 4 Comparison of clinical course curves of the IBSEN study.
A: Graphs of self-identified clinical course in the IBSEN study[6]; B: Actual clinical course according to pediatric ulcerative colitis activity index prior to the introduction of infliximab (Group A); C: Actual clinical course according to pediatric ulcerative colitis activity index after the introduction of infliximab (Group B). n: Number.
- Citation: Kwon Y, Kim ES, Choe YH, Kim MJ. How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study. World J Gastroenterol 2022; 28(28): 3666-3681
- URL: https://www.wjgnet.com/1007-9327/full/v28/i28/3666.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i28.3666